Advertisement
Advertisement
Trending on Psychiatric Times
1
NIDA Awards PleoPharma $6.5 Million Grant to Advance Phase 3 Trial of PP-01 for Cannabis Use Disorder
2
Objective Measurement for Psychiatry: Universal Brain's ERP System
3
HLP003, Deuterated Psilocin, as an Adjunctive Therapy for Major Depressive Disorder
4
Podcast: Integrative Approaches to Chronic Pain With Julia Rodes, MD
5